LetterLetter
Dr. Triantafyllias, et al reply
Konstantinos Triantafyllias, Caroline Heller, Michele de Blasi, Peter Robert Galle and Andreas Schwarting
The Journal of Rheumatology March 2021, jrheum.201636; DOI: https://doi.org/10.3899/jrheum.201636
Konstantinos Triantafyllias
ACURA Rheumatology Center Rhineland-Palatinate, Bad Kreuznach; Internal Medicine I, Department of Rheumatology and Clinical Immunology, Johannes Gutenberg University Medical Center, Mainz; Internal Medicine I, Department of Gastroenterology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany. The authors declare no financial support or other benefits from commercial sources for the work reported in the correspondence, or any other financial interests that any of the authors may have, which could create a potential conflict of interest or the appearance of a conflict of interest with regard to the work. Address correspondence to Dr. K. Triantafyllias, ACURA Rheumatology Center, Kaiser-Wilhelm-Str. 9-11, 55543, Bad Kreuznach, Germany. Email: ktriantafyllias@gmail.com.
Caroline Heller
ACURA Rheumatology Center Rhineland-Palatinate, Bad Kreuznach; Internal Medicine I, Department of Rheumatology and Clinical Immunology, Johannes Gutenberg University Medical Center, Mainz; Internal Medicine I, Department of Gastroenterology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany. The authors declare no financial support or other benefits from commercial sources for the work reported in the correspondence, or any other financial interests that any of the authors may have, which could create a potential conflict of interest or the appearance of a conflict of interest with regard to the work. Address correspondence to Dr. K. Triantafyllias, ACURA Rheumatology Center, Kaiser-Wilhelm-Str. 9-11, 55543, Bad Kreuznach, Germany. Email: ktriantafyllias@gmail.com.
Michele de Blasi
ACURA Rheumatology Center Rhineland-Palatinate, Bad Kreuznach; Internal Medicine I, Department of Rheumatology and Clinical Immunology, Johannes Gutenberg University Medical Center, Mainz; Internal Medicine I, Department of Gastroenterology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany. The authors declare no financial support or other benefits from commercial sources for the work reported in the correspondence, or any other financial interests that any of the authors may have, which could create a potential conflict of interest or the appearance of a conflict of interest with regard to the work. Address correspondence to Dr. K. Triantafyllias, ACURA Rheumatology Center, Kaiser-Wilhelm-Str. 9-11, 55543, Bad Kreuznach, Germany. Email: ktriantafyllias@gmail.com.
Peter Robert Galle
ACURA Rheumatology Center Rhineland-Palatinate, Bad Kreuznach; Internal Medicine I, Department of Rheumatology and Clinical Immunology, Johannes Gutenberg University Medical Center, Mainz; Internal Medicine I, Department of Gastroenterology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany. The authors declare no financial support or other benefits from commercial sources for the work reported in the correspondence, or any other financial interests that any of the authors may have, which could create a potential conflict of interest or the appearance of a conflict of interest with regard to the work. Address correspondence to Dr. K. Triantafyllias, ACURA Rheumatology Center, Kaiser-Wilhelm-Str. 9-11, 55543, Bad Kreuznach, Germany. Email: ktriantafyllias@gmail.com.
Andreas Schwarting
ACURA Rheumatology Center Rhineland-Palatinate, Bad Kreuznach; Internal Medicine I, Department of Rheumatology and Clinical Immunology, Johannes Gutenberg University Medical Center, Mainz; Internal Medicine I, Department of Gastroenterology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany. The authors declare no financial support or other benefits from commercial sources for the work reported in the correspondence, or any other financial interests that any of the authors may have, which could create a potential conflict of interest or the appearance of a conflict of interest with regard to the work. Address correspondence to Dr. K. Triantafyllias, ACURA Rheumatology Center, Kaiser-Wilhelm-Str. 9-11, 55543, Bad Kreuznach, Germany. Email: ktriantafyllias@gmail.com.
Abstract
We have read with great interest the letter of Verhoeven, et al,1 referring to our recent publication on the diagnostic value of optical spectral transmission (OST) in rheumatoid arthritis (RA).2 In our work we had described for the first time, to our knowledge, that OST values could be influenced not only by disease-associated factors (i.e., inflammatory activity) but also by patient-associated characteristics, such as sex, BMI, and age.2
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Dr. Triantafyllias, et al reply
Konstantinos Triantafyllias, Caroline Heller, Michele de Blasi, Peter Robert Galle, Andreas Schwarting
The Journal of Rheumatology Mar 2021, jrheum.201636; DOI: 10.3899/jrheum.201636